Teva Pharmaceutical reported 1.99B in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Aspen Pharmacare APN:SJ 9.45B 480M
Cipla CIPLA:IN 20.69B 2.46B
Dr.Reddys Laboratories DRRD:IN 17.02B 1.61B
Guangzhou Baiy 600332:CH 13.06B 2.49B
Jiangsu Hengrui Me. 600276:CH CH 843.82M 66.58M
Kalbe Farma Tbk Pt KLBF:IJ 3604.85B 236.63B
Richter Gedeon RICHT:HB 67.68B 4.99B
Sh Fosun Pharma 600196:CH CH 4.29B 462.45M
Sun Pharmaceuticals SUNP:IN IR 26494.3M 4086.7M
Teva Pharmaceutical TEVA:IT 1.99B 76M